This document provides guidelines for managing adverse events following immunization (AEFI). It states that vaccination sites and supervisors will provide initial treatment for AEFI and all centers should be equipped with AEFI treatment kits. Serious AEFI cases should be immediately referred to health facilities and costs will be covered. It also details the components of an AEFI treatment kit including drugs, equipment, dosage charts, and guidelines for recognizing and managing anaphylaxis including giving adrenaline and hydrocortisone injections.
1 of 18
Downloaded 267 times
More Related Content
AEFI in Immunization
1. For More Health Information Log On To My Website
www.vdcure.com
AEFI
Adverse Events Following Immunization
2. The vaccinators and the
supervisors at the vaccination
site will provide primary
management for AEFIs.
All sub centers should be prepare for facing any
kind of AEFI with AEFI treatment kit.
3. Serious AEFIs:
Refer immediately to the nearest
health facility/AEFI management
centre, and reported to the
appropriate authority.
Transportation costs will be borne
through untied funds with Village
Health and Sanitation Committee
(VHSC).
7. Equipment
Disposable Syringe (insulin type) having
0.01 ml graduations and 26G IM needle – 2
sets
Disposable Syringe (5 ml) and 24/26G IM
needle – 2 sets
Scalp vein set – 2 sets
IV drip set: 1 set
Cotton wool + adhesive tape : 1 each
At hospital setting, Oxygen support and
airway intubation facility should be
available.
8. Info/reports/Records: Label
showing: Date of inspection, Expiry
date of Inj. Adrenaline and shortest
expiry date of any of the
components
Drug dosage tables for Inj
Adrenaline and Hydrocortisone
9. Management of a case of anaphylaxis
Recognition of anaphylaxis-1
• Anaphylaxis ( a very rare at ~1/one million doses of
measles vaccine given) but severe and potentially
fatal allergic reaction,
• When anaphylaxis occurs, the patient must be
diagnosed properly, treated, and managed urgently
by trained staff and transferred to a hospital setting,
• The vaccinators, paramedics and physicians should be
adequately trained
– to able to distinguish anaphylaxis from fainting
(Vasovagal syncope), anxiety and breath-holding
spells, which are common benign reactions.
– During fainting, individual suddenly becomes pale,
loses consciousness and collapses to the ground.
Fainting requires no specific treatment or
investigation.
11. Management of anaphylaxis
• Once diagnosis is made, consider patient being in
a potentially fatal condition, regardless of the
severity of the current symptoms.
• Begin treatment immediately,
• In addition, make plans to transfer the patient
immediately to the hospital (if not already in a
hospital setting).
• As described earlier, make easy availability of
AEFI treatment kit
12. Steps in managAenamphyelanxist? of anaphylaxis
Assess ABC: Airway/Breathing/Circulation
Diagnosis: Look for Acute onset of illness/Life
threatening problems with A-B-C/Skin
changes
Call for help/Lie patient flat/Raise patient’s
legs/Keep airway clear/If necessary give CPR
Inj. Adrenaline IM (1:1000 solution)
Per dosage chart
Inj Hydrocortisone [see dosage chart]
Refer to next level, as needed
In hospital settings: Establish airway/High flow
oxygen/IV fluids
13. Management of anaphylaxis
• Give adrenaline 1:1000 (age appropriate dose) by deep
i/m injection into opposite limb, Give an additional half
dose around the injection site (to delay antigen
absorption).
• If no improvement, repeat within 10-20 minutes of the
first injection, up to a maximum of three doses, in total.
• Give Inj. Hydrocortisone IM or slow IV per dosage
• If patient conscious after adrenaline is given, place
his/her head lower than the feet and keep the patient
warm.
• Give oxygen by face mask, if available.
• Mark the immunization card clearly to prevent future
repeat dose of offending vaccine.
• Report anaphylaxis to the appropriate officer
14. Doses of Adrenaline and Hydrocortisone
Alternatively, 1:1000 adrenaline (epinephrine) at a dose of 0.01ml/kg up to a
maximum of 0.5 ml injected intramuscularly (or subcutaneously in very mild cases)
may be given
15. Note on Adrenaline dosage
• 1 in 1000 solution means
– 1g of adrenaline in 1000 ml of solution
– 1000 mg of adrenaline in 1000 ml of solution
– Or, 1 mg of adrenaline in 1 ml of solution
– Or 0.01 mg of adrenaline in 0.01 ml of solution
• Adrenaline dosage is 0.01 ml/kg of body weight
• For a syringe which has 1 ml divided into 100 small divisions, each
small division = 0.01 ml
– So adrenaline dosage is easy to calculate and administer with such a
syringe
• Example: A child with body weight 12 Kg will need 0.12 ml of
adrenaline = 12 small divisions of the syringe.
17. Summary
• Measles vaccine is a safe and effective vaccine.
• AEFI due to programme errors must be prevented at all
costs,
• Very rarely, measles vaccine can cause serious AEFI
(e.g. anaphylaxis), which must be treated promptly,
• All Govt. facilities ( PHC upwards) will function as
AEFI management centres with designated medical
officers,
• All AEFI management centres must be fully equipped
with AEFI treatment kits and protocols, prominently
displayed.
• The standard guidelines should be followed in all cases.
18. For More Health Information Log
On To Thank My Website
You
www.vdcure.com